Ki-67 labeling index in glioblastoma; does it really matter?
Objective/Background: Glioblastoma (GB) is the most common primary malignant brain tumor in adults. Ki-67 is a nonhistone nuclear protein that is expressed by cells entering the mitotic cycle and is associated with the transcription of ribosomal RNA (rRNA). In gliomas, the extent of expression of Ki...
Main Authors: | Ali Alkhaibary, Ali H. Alassiri, Fahd AlSufiani, Mohammed A. Alharbi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387618301158 |
Similar Items
-
Chondro-Osseous Metaplasia in Ependymoma: A Rare Histopathological Finding
by: Ali Alkhaibary, et al.
Published: (2020-01-01) -
O6-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma
by: Ali H. Alassiri, et al.
Published: (2019-12-01) -
Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma
by: Brigita Glebauskiene, et al.
Published: (2018-01-01) -
New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas.
by: Wielisław Papierz, et al.
Published: (2010-05-01) -
Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma
by: Pingping Wang, et al.
Published: (2021-06-01)